Q2 FY2026 · ended Jun 30, 2026 · Revenue $5.18M, -3.6% YoY · Filed Aug 11, 2026
DarioHealth Corp. (DRIO) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $5.2 million and a net loss of $7.9 million. Free cash flow was -$6.1 million. As of Jun 30, 2026 it held $14.0 million in cash and investments and $32.4 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DRIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1533998
- Former names
- LabStyle Innovations Corp. (until Jul 27, 2016)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.2M | $5.6M | $5.2M | $5.0M | $5.4M |
| Operating income | -$6.5M | -$7.3M | -$8.6M | -$9.5M | -$9.2M |
| Net income | -$7.9M | -$8.2M | -$9.0M | -$10.5M | -$13.0M |
| Diluted EPS | $0.85 | $1.25 | -$1.15 | $2.96 | $3.54 |
| Operating cash flow | -$6.1M | -$6.0M | -$5.9M | -$7.3M | -$6.0M |
| Free cash flow | -$6.1M | -$6.1M | -$5.9M | -$7.4M | -$6.1M |
| Total assets | $96.6M | $103.3M | $110.1M | $117.7M | $108.3M |
| Stockholders' equity | $55.1M | $62.4M | $67.9M | $74.9M | $64.0M |
| Cash and investments | $14.0M | $20.0M | $21.8M | $31.9M | $22.0M |
| Total debt | $32.4M | $31.8M | $31.7M | $31.6M | $31.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 4, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 22, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2026 | Jul 10, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 903 DarioHealth Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.